Sanderling Ventures

Sanderling Ventures is a biomedical investment firm founded in 1979 that partners with entrepreneurs to build life sciences companies. Its model combines early-stage financing - including seed funding and support through later-stage rounds - with active, hands-on management and operational involvement in the businesses it backs. The firm has supported more than 90 biomedical companies.

The firm's technical coverage spans small-molecule therapeutics, biologics, vaccines, drug delivery, platform technologies and medical devices, together with regulatory expertise. Beyond capital, Sanderling provides portfolio companies with management leadership, decision-making support, strategic development and recruiting assistance, alongside accounting, financial support and cost-control strategies. Technical and regulatory know-how and access to outside resources are supplied so that founders can concentrate on technology development and commercial applications.

Sanderling works with companies from very early-stage start-ups through commercial development, positioning itself as a long-term partner rather than a passive investor. The stated approach couples capital with management capacity building - a model suited to biomedical ventures, where scientific progress must be matched by operational and regulatory execution. Further information is available at sanderling.com.